TEL (Translocation ± ETS ± Leukemia or ETV 6) is disrupted by multiple chromosomal translocations in acute leukemia. The loss of heterozygosity at the TEL locus in leukemias and the hemizygous deletion of TEL that is observed in various tumors, suggests that TEL is a tumor suppressor. Overexpression of TEL alters cellular morphology and represses the expression of the matrix metalloproteinase stromelysin-1. Based on these studies, deletion analysis was used to de®ne the minimal repression domains of TEL. TEL-mediated repression required both the N-terminal pointed domain and a central region composed of amino acids 268 ± 303. The mSin3A and N-CoR corepressors bind to the pointed domain and the central repression domain of TEL, respectively. Unexpectedly, histone deacetylase-3, but not other histone deacetylases, also associates with the central region of TEL. Histone deacetylase-3 interacts with a TEL mutant that cannot bind N-CoR, suggesting that this is a direct interaction with TEL. In addition, histone H3 was under-acetylated near the TEL-binding sites in the endogenous stromelysin-1 promoter when TEL was expressed. Furthermore, trichostatin A, a potent histone deacetylase inhibitor, impaired TELdependent repression of the stromelysin-1 promoter. Finally, while TEL-expression induced cellular aggregation of Ras-transformed cells, Trichostatin A reversed the TEL-induced cellular aggregation phenotype. Thus, the cumulative data suggests that histone deacetylase-3 activity is required for the transcriptional functions of TEL. Oncogene (2001) 20, 3716 ± 3725.
Introduction
TEL (Translocation ± ETS ± Leukemia) was originally identi®ed as the gene on chromosome 12p13 that is disrupted by various chromosomal translocations including t(12;21), t(5;12), and t(9;12) (Golub et al., 1994 (Golub et al., , 1995 . The t(12;21) is found in approximately 25% of pediatric B-cell acute leukemia and it creates a fusion protein between the N-terminus of TEL (ETV 6) (residues 1 ± 336) and the AML-1 (Runx-1) transcription factor (residues 21 ± 480). In most of the leukemias containing the t(12;21), the other allele of TEL is deleted, indicating that loss of TEL function contributes to leukemogenesis (Raynaud et al., 1996; Romana et al., 1996; Stegmaier et al., 1995) . Loss of at least one TEL allele is also observed in various solid tumors including breast and ovarian cancers, suggesting that TEL plays an important role in tumorigenesis (Hatta et al., 1997; Spirin et al., 1996) .
TEL shares homology with ETS factors within the evolutionarily conserved ETS domain (the DNA binding domain) and an N-terminal`pointed' domain that is homologous with the Drosophila protein Pointed, which acts during development (Scholz et al., 1993) . Homozygous deletion of TEL in mice lead to a severe defect in the developing vascular network of the yolk sac with embryonic lethality at E10.5 (Wang et al., 1997) . TELnull embryonic stem cells did not contribute to the adult bone marrow in chimeric mice, suggesting a defect in cell migration or cell adhesion of stem cells (Wang et al., 1997 (Wang et al., , 1998 . In addition, when TEL was expressed in Ras-transformed NIH3T3 cells, TEL inhibited cell growth (Fenrick et al., 2000; Van Rompaey et al., 2000) and induced cellular aggregation (Fenrick et al., 2000; Van Rompaey et al., 1999) . TEL also repressed the expression of stromelysin-1 (Fenrick et al., 2000) , an extracellular matrix metalloproteinase (MMP) that remodels the extracellular matrix (Lochter et al., 1997; Wiesen and Werb, 1996) . MMPs are required for angiogenesis, tissue remodeling, and tumor cell invasion (Basbaum and Werb, 1996) . Consistent with the TELmediated inhibition of stromelysin-1, tumors expressing TEL were impaired in their ability to invade the surrounding muscle (Fenrick et al., 2000) . Thus, TEL may play a role in growth control and cell adhesion.
TEL is a transcriptional repressor when using either heterologous or bona ®de regulated promoters (Chakrabarti and Nucifora, 1999; Fenrick et al., 1999 Fenrick et al., , 2000 Kwiatkowski et al., 1998a; Lopez et al., 1999) . TEL repression was associated with the binding of the corepressors mSin3A and SMRT/N-CoR (Chakrabarti and Nucifora, 1999; Fenrick et al., 1999; Guidez et al., 2000) . mSin3A was ®rst identi®ed as required for MAD : MAX-mediated repression and it is a mammalian homologue of Saccaromyces cerevisae corepressor Sin3p (Ayer et al., 1995; Rao et al., 1996; Vidal et al., 1991) . SMRT and N-CoR are related factors that were initially identi®ed as corepressors for nuclear hormone receptors (Ayer et al., 1995; Chen and Evans, 1995; Chen et al., 1996; Horlein et al., 1995) . SMRT/N-CoR and mSin3A or mSin3B associate with each other and with histone deacetylases to mediate repression by a variety of DNA binding-transcriptional repressors (Alland et al., 1997; Hassig et al., 1997; Heinzel et al., 1997; Kadosh and Struhl, 1997; Laherty et al., 1997; Lutterbach et al., 1998; Nagy et al., 1997; Zhang et al., 1997) . Recruitment of histone deacetylases to the target promoter causes the deacetylation of histones, predominantly histones H3 and H4 (Luo and Dean, 1999) . The histone deacetylation facilitates chromatin condensation and renders the promoter less accessible to the transcriptional machinery (Pazin and Kadonaga, 1997; Struhl, 1998) .
Histone deacetylases can be divided into three subgroups. The class I enzymes are homologous to a yeast protein RPD3 and include HDAC-1, -2, -3 and -8 (Cress and Seto, 2000; Hu et al., 2000) . The class II enzymes are homologous to yeast HDA1 and include HDAC-4, -5, -6, and -7. (Fischle et al., 1999; Grozinger et al., 1999; Hu et al., 2000; Kao et al., 2000; Miska et al., 1999; Taunton et al., 1996; Verdel and Khochbin, 1999; Yang et al., 1997) . In addition, there is a class of NAD-dependent HDACs that are homologous to Sir2 from yeast (Guarente, 2000; Imai et al., 2000; Landry et al., 2000) . Thus, a complex network of histone deacetylases and corepressors regulates the transcriptional activity of repressors including tumor suppressors such as the retinoblastoma protein and p53 (Luo et al., 1998; Murphy et al., 1999 ).
Here we demonstrate that histone deacetylase-3 activity is required for TEL function in transcriptional repression. Both the pointed domain and a central repression domain are essential for TEL functions. TEL interacts with mSin3A and N-CoR through the pointed domain and the central repression domain, respectively. In addition, HDAC-3 speci®cally binds TEL via the central repression domain. Chromatin immunoprecipitation (CHIP) assays showed that histone H3 on the stromelysin-1 promoter was deacetylated by TEL expression. Moreover, a histone deacetylase inhibitor inactivated TEL in a biological assay. Together these results suggest that TEL recruits histone deacetylase-3 to alter target gene expression and biological phenotypes.
Results

Mapping of repression domains of TEL
The`pointed' domain is sucient to bind the mSin3A corepressor (Fenrick et al., 1999) , while the central domain of TEL can interact with SMRT or N-CoR (Chakrabarti and Nucifora, 1999; Guidez et al., 2000) . In addition, deletion analysis suggested that a second mSin3A interaction domain might be present in TEL (Chakrabarti and Nucifora, 1999) , although this interaction could be mediated by SMRT (Nagy et al., 1997; Wong and Privalsky, 1998) . Having identi®ed the stromelysin-1 promoter as the ®rst endogenous promoter that is regulated by TEL (Fenrick et al., 2000) , we sought to further characterize the mechanism of TEL-mediated repression. We constructed a panel of TEL deletion mutants and tested these mutants for their ability to repress the stromelysin-1 promoter in transient assays ( Figure 1a ). As observed previously (Fenrick et al., 2000) , deletion of the pointed domain of TEL ablated TEL-mediated repression (Figure 1b) . In addition, deletion of the domain between the pointed domain and the t(12;21) breakpoint, a domain that binds SMRT (Chakrabarti and Nucifora, 1999) , also abrogated repression. Therefore, multiple corepressor contacts are required for TEL-mediated repression ( Figure 1b ). Using this assay we further re®ned the central TEL repression domain. Progressive internal deletion of the residues from the pointed domain (residue 122) up to the ETS domain indicated NIH3T3 cells were transfected with 1 mg pGL2 ± 754TR reporter plasmid and 100 ng of dierent deletion mutants. 200 ng of pCMV ± SEAP was used as internal control. The experiments were done in duplicate and the average deviation is shown that removal of residues 122 ± 268 was tolerated in this assay. By contrast, deletion of residues 268 ± 333 impaired TEL-mediated repression.
TEL interacts with mSin3A and N-CoR through independent domains
Having re®ned the transcriptional repression domains of TEL we used the panel of deletion mutants to de®ne corepressor-binding domains. N-CoR is related to SMRT and cooperated with a GAL4 ± TEL fusion protein to repress transcription from an arti®cial promoter (Chakrabarti and Nucifora, 1999; Guidez et al., 2000) . Therefore, we tested whether N-CoR could interact with the minimal TEL-repression domains. FLAG-tagged N-CoR was coexpressed with TEL and cell lysates were immunoprecipitated with FLAG antibodies. TEL interacted with N-CoR in relatively stringent conditions (PBS/0.5% Triton X-100/0.1% SDS; Figure The functional consequences of the TEL : N-CoR association were further tested using the stromelysin-1 promoter for transient transcription assays. Because endogenous N-CoR is expressed at relative low levels in NIH3T3 cells, we cotransfected TEL and N-CoR to determine if TEL can cooperate with N-CoR to repress the stromelysin-1 promoter. TEL-mediated repression was augmented by the addition of N-CoR while expression of N-CoR alone had no eect ( Figure 2b ). By contrast, N-CoR did not cooperate with the TELD268-333 mutant to repress the stromelysin-1 promoter, con®rming that amino acids 268 ± 333 of TEL are required to functionally interact with N-CoR.
The pointed domain of TEL is sucient for binding to mSin3A (Fenrick et al., 1999) . Using the panel of TEL mutants we asked if other regions of TEL are also needed for mSin3A binding. TEL and several of the TEL mutants co-migrate with the IgG heavy chain. Therefore, we immunoprecipitated cell lysates with TEL antibodies and detected co-purifying mSin3A by immunoblot analysis (Figure 3 ). TEL interacted with mSin3A, but both TELDP and TELDP/D268-333 failed to associate with mSin3A under these conditions ( Figure 3 ). Additional mutants that retained the pointed domain (D268-333, D122-268 and D122-333) interacted with mSin3A suggesting that the region between residues 122 ± 333 are not required for mSin3A Histone deacetylase-3 is present in the TEL repression complex mSin3A represses transcription by interacting with HDAC-1, -2 and -3, but it also acts independently of histone deacetylases (Kadosh and Struhl, 1997; Struhl, 1998; Wong and Privalsky, 1998) . N-CoR and SMRT binds a subset of the known HDACs, including HDAC-3, -4, -5 and -7 (Huang et al., 2000; Li et al., 2000; Wen et al., 2000) . Therefore, we tested representative members of the class I and class II families of HDACs for association with TEL. TEL was cotransfected with FLAG-tagged HDAC1-6, which allowed a direct comparison of binding speci®city using the same antibody for detection. Cell lysates were split and immunoprecipiated with either TEL or FLAG antibodies. TEL and HDACs were detected by immunoblot analysis. TEL co-puri®ed with HDAC3 immune complexes and HDAC3 co-puri®ed with TEL immune complexes (Figure 4a,b) . However, no other HDAC associated with TEL, with the possible exception of HDAC-2 or HDAC-4, for which very weak signals were detected (Figure 4a,b) . The observation that TEL interacts with HDAC-3 raised the possibility that the t(12;21) fusion protein TEL/AML-1 also can bind HDAC-3. Therefore, TEL/ AML-1 and HDAC-3 expression plasmids were cotransfected and the possible association determined after immunoprecipitation. TEL/AML-1 was detected in anti-FLAG immunoprecipitates only when the proteins were co-expressed, indicating that the fusion protein can indeed bind HDAC-3 (labeled T/A in Figure 4c ). Thus, TEL must contact HDAC-3 within residues 1 ± 336.
To further map the interaction domain on TEL, we co-transfected plasmids expressing TEL deletion mutants ( Figure 1a ) and epitope tagged HDAC-3. The HDAC-3 interaction was disrupted by the deletion of amino acids 268 ± 333, but not by deletion of the pointed domain ( Figure 5 ). However, deletion of residues 122 ± 268 appeared to reduce the amount of TEL that co-puri®ed with this fragment (Figure 5 , lower panel), suggesting the presence of a weak binding site. Because the 268 ± 333 deletion disrupts the interactions between TEL and N-CoR and because HDAC-3 associates with N-CoR (Wen et al., 2000) , we further subdivided this domain. Deletion of TEL residues 268 ± 303 signi®cantly impaired the interaction with N-CoR (Figure 6a , left panels), whereas neither deletion of residues 268 ± 303 or 303 ± 333 signi®cantly aected the interaction between TEL and HDAC-3 Figure 3 TEL associates with mSin3A independent of the central repression domain. The indicated TEL mutants were transfected into Cos-7 cells and the lysates were prepared in PBS with 0.5% Tritron X-100 and 0.1% SDS and immunoprecipitated by using antibodies against the N-terminal TEL. TEL and mSin3A were detected by Western blot using antibodies against the C-terminal TEL and mSin3A (K-20, Santa Cruz). A strong band of IgG heavy chain is also shown as indicated which covered the mutants TELDP and TELD268-333 with the similar molecular weights in immunoprecipitation blot Figure 4 HDAC3 is associated with TEL. FLAG-tagged HDAC1-6 were co-transfected with TEL into Cos-7 cells. The extracts were immunoprecipitated with anti-FLAG monoclonal antibody conjugated agarose (a), or with anti-TEL (b). (c) TEL/ AML-1 binds HDAC-3. Immunoprecipitation followed by immunoblot analysis was done essentially as in (a), but using plasmids expressing TEL/AML1 and HDAC-3. The TEL/AML-1 immunoblot was performed using anti-N-terminal TEL serum (Fenrick et al., 1999) . T/A/ TEL/AML-1 (Figure 6a , right panels). This latter result implies that HDAC-3 either interacts with an extended domain in TEL or that it contacts TEL twice. Transcriptional analysis of these TEL mutants using the stromelysin-1-luciferase reporter plasmid indicated that TELD268-303, which was defective in N-CoR binding, was also impaired for transcriptional repression, while TELD303-333 displayed an intermediate level of repression (Figure 6b) . Thus, multiple contacts between TEL and co-repressors are required for full TELmediated repression.
TEL-expression alters histone acetylation of the stromelysin-1 promoter TEL represses stromelysin-1 by binding at least two sequences in the promoter, a classical ETS-factor binding site and another binding site located 795 to 7103 nucleotides to the transcription initiation site (Fenrick et al., 2000) . The association between TEL and HDAC-3 suggested that TEL repressed transcription by altering histone acetylation. To directly test this hypothesis, we used the endogenous stromelysin-1 promoter for chromatin immunoprecipitation (CHIP) assays with anti-acetylated histone H3 antibodies. This antibody has been used in yeast and tetrahymena to detect the amount of acetylated histone H3 associated with a speci®c promoter (Braunstein et al., 1993; Dedon et al., 1991) . NIH3T3 cells expressing an oncogenic Ras mutant expressed high levels of endogenous stromelysin-1 and expression of TEL in these cells repressed stromelysin-1 expression (Fenrick et al., 2000) . Cells expressing Ras or both Ras and TEL were brie¯y treated with formaldehyde to crosslink histones to DNA, chromosomal DNA was fragmented by sonication, and the protein/DNA conjugates were immunoprecipitated with anti-acetylhistone H3. The sequences near the TEL binding sites in the stromelysin-1 promoter that were crosslinked to acetylated histones were detected by PCR. In parental Ras-expressing NIH3T3 cells the PCR product with the predicted size was readily detected using antiacetylated histone H3 (Figure 7 , lane 4), but not preimmune serum (Figure 7 , lanes 3 and 6), indicating that acetylated forms of histone H3 are associated with 
Histone deacetylase activity is required for TEL function
The disruption of both TEL loci in leukemias containing the t(12;21) suggests that TEL is a tumor suppressor. When expressed in Ras-transformed NIH3T3 cells, TEL inhibited cell growth and caused cellular aggregation. This latter phenotype was correlated with the repression of stromelysin-1 (Fenrick et al., 2000) . Given the association of TEL with HDAC-3, we asked if TEL requires histone deacetylase activity to alter stromelysin-1 promoter function and biological phenotypes by using the histone deacetylase inhibitor trichostatin A (TSA). The levels of endogenous stromelysin-1 mRNA were signi®cantly enhanced by addition of trichostatin A to the culture media in NIH3T3 cells expressing Ras and TEL (data not shown). However, trichostatin A also caused the induction of stromelysin-1 in the absence of TEL overexpression (data not shown). Therefore, we tested the eects of trichostatin A in transient assays.
Although TSA often has only marginal eects in transient assays, 150 nM TSA added to the culture medium reversed TEL-mediated repression by approximately 70% (Figure 8a ), indicating that TEL requires histone deacetylase activity to repress transcription. TEL expression in Ras-transformed NIH3T3 cells caused an aggregation phenotype under subcon¯uent culture conditions. This phenotype required the pointed domain of TEL and was linked to the repression of stromelysin-1 (Fenrick et al., 2000) . To ask if this phenotype required histone deacetylase activity, we treated the Ras+TEL-expressing cells with 150 nM TSA. Treatment with the solvent alone (DMSO) did not change the TEL-induced phenotype (Figure 8b) . By contrast, 48 h after treatment with TSA, TEL-expressing cells had lost the typical aggregation phenotype (Figure 8b) . Thus, histone deacetylase activity is required for TEL-mediated transcription and for altering biological phenotypes.
Discussion
Enforced expression of TEL inhibits expression of stromelysin-1 and causes a cell aggregation phenotype (Fenrick et al., 2000) . We took advantage of these assays to further dissect the mechanism of TEL- Figure 7 Overexpression of TEL decreases the acetylated histone H3 on the stromelysin-1 promoter. TEL was introduced into Ras-transformed NIH3T3 cells. The cell extracts were processed and CHIP assay was done as in the Materials and methods. The association between histone H3 and stromelysin-1 promoter was determined by using anti-acetylated histone H3 antibody followed by PCR ampli®cation of coimmunoprecipitated chromatin. The PCR product (*200 bp) was then separated on 1% agarose gel NIH3T3 cells were transfected with 1 mg of pGL2 ± 754TR reporter plasmid and 100 ng TEL in the absence or presence of 150 nM TSA, and 200 ng of the cytomegalovirus immediate early promoter-secreted alkaline phosphatase plasmid (pCMV ± SEAP) as an internal control. The bars present average results of duplicate experiments. (b) TSA reverses the aggregation phenotype caused by TEL. TEL expressing Ras ± NIH3T3 were split 1 : 8 and further cultured in the presence of 150 nM TSA. At 48 h after TSA treatment the cells were examined under microscope for the phenotype mediated repression. Using the stromelysin-1 promoter as a native target for TEL-dependent repression, we demonstrated that contacts with mSin3 and N-CoR and/or HDAC-3 were required for TEL-dependent repression. Further, chromatin immunoprecipitation assays were used to show that TEL expression alters the pattern of histone H3 acetylation near the TELbinding sites on the stromelysin-1 promoter. Finally, using the cell aggregation assay, we demonstrated that TEL requires histone deacetylase activity to alter cell morphology.
TEL requires both the pointed domain and the central repression domain to repress transcription (Figure 1 and (Chakrabarti and Nucifora, 1999; Lopez et al., 1999) ). The pointed domain interacts with mSin3A and the central domain interacts with NCoR. Both of these contacts contribute to repression as indicated by the deletion of the pointed domain and residues 268 ± 303 (Figures 1 and 6 ). In addition, the central domain interacted speci®cally with HDAC-3. This was unexpected due to the high degree of homology between the class I HDACs (Emiliani et al., 1998) . This speci®city may begin to explain why multiple class I and class II histone deacetylases are expressed in the same cell type. Yet even with this speci®c interaction, multiple contacts between TEL and corepressors are required for TEL-dependent repression, indicating that simply binding HDAC-3 is not sucient for repression.
A complex network exists among corepressors and histone deacetylases. HDAC-1, -2 and -3 associated with mSin3A (Kadosh and Struhl, 1997; Struhl, 1998) , whereas N-CoR and SMRT interact directly with HDAC-3, -4, -5 and -7 (Huang et al., 2000; Li et al., 2000; Wen et al., 2000) . HDAC-3 not only binds to NCoR, but its interaction with N-CoR augments the enzymatic activity of HDAC-3 (Wen et al., 2000) . This observation may explain why N-CoR and HDAC-3 bind to the same region of TEL and that loss of NCoR impaired TEL-mediated repression even though the TEL mutant (TELD268-303) retained the ability to bind HDAC-3 (Figure 6 ). N-CoR and SMRT also associated the mSin3A through domains that are distinct from HDAC-binding domains Wen et al., 2000) . Thus, TEL may bind mSin3A, SMRT or N-CoR, and HDAC-3 to create a repression complex and removal of any one component of the complex impairs TEL action (Figures 1, 2, 3 and 6).
The ETS family encompasses over 30 dierent genes (Graves and Petersen, 1998) . Although several dierent ETS family members can repress transcription, TEL is the ®rst to be linked to histone deacetylases. Another ETS factor that is homologous to TEL, TEL2 or TELB, was recently identi®ed through sequence homology (Poirel et al., 2000; Potter et al., 2000) . This gene encodes a protein of 341 amino acids, which is 38% identical to TEL. TEL2 is very homologous to TEL in the pointed domain (62.5% identity) and the ETS domain (85.4% identity). However, TEL2 contains only 108 amino acids separating the pointed domain and the ETS domain, while the same region in TEL is over twice as long. As this dierence would predict, a Lipman-Pearson sequence alignment found that TEL2 shares only approximately 30% identity with TEL within the N-CoR/HDAC-binding domain. Thus, TEL2 may bind a dierent complement of corepressors. This may in¯uence our modeling of TEL function because TEL not only homodimerizes (Fenrick et al., 1999; Lopez et al., 1999) , but heterodimerizes with TEL2 and Fli1 (Kwiatkowski et al., 1998b; Potter et al., 2000) . While the interaction with Fli1 appeared to block Fli1-dependent transactivation (Kwiatkowski et al., 1998b) , the interaction with TEL2 could increase TEL-mediated repression or alter target gene speci®city, perhaps in a mSin3A-dependent manner.
The loss of heterozygosity of TEL indicates that TEL is a tumor suppressor. A group of tumor suppressors share a similar mechanism of transcriptional repression with TEL. The retinoblastoma protein (pRb) regulates the G 1 /S phase transition of the cell cycle. A key in this cell cycle control is that pRb binds HDAC-1 and E2F transcription factors to suppress E2F-dependent transcription (Chellappan et al., 1991; Luo et al., 1998) . Likewise, the p53 tumor suppressor binds mSin3 corepressors to repress transcription (Murphy et al., 1999) . In several experimental systems, it is p53-mediated repression that appears responsible for the induction of apoptosis (Caelles et al., 1994; Haupt et al., 1995) . Overexpression studies indicated that TEL can inhibit the growth and invasiveness of Ras-transformed cells (Fenrick et al., 2000) , further supporting the hypothesis that TEL is a tumor suppressor. The ability of TEL to inhibit cell growth and alter cell morphology was correlated with repressing stromelysin-1 and inhibiting MMP function (Fenrick et al., 2000) . Further, trichostatin A inactivated TEL-mediated repression (Figure 8a and (Chakrabarti and Nucifora, 1999) ) and reversed TEL-mediated cellular aggregation (Figure 8b ). The speci®c interaction between TEL and HDAC-3 is also highlighted by the observation that HDAC-3 is located within a region on Chromosome 5 that is commonly deleted in myeloid leukemias (Mahlknecht et al., 1999) . Thus, a common feature of these tumor suppressors is the requirement of active histone deacetylases to alter biological phenotypes.
The domains of TEL that bind mSin3A, HDAC-3, and N-CoR are fused to AML-1 by the t(12;21). AML-1 both activates and represses transcription, with repression dependent on interactions with mSin3A and the Groucho/TLE family of co-repressors (Javed et al., 2000; Levanon et al., 1998; Lutterbach et al., 2000) . Previously we demonstrated that the fusion of TEL and AML-1 lead to near stiochometric binding to mSin3A (Fenrick et al., 1999) . The demonstration that the (t12;21) fusion protein also binds histone deacetylase-3 to repress transcription, suggests that therapies that target HDAC-3 might prove to be bene®cial to these patients.
Materials and methods
Plasmids
The pBabePuro-TEL and pCMV-TEL, and pCMVTELDP, were previously described (Fenrick et al., 2000) . PCMV-TELDP/D268-333, pCMVTELD268-333, pCMVTELD122-176, PCMVTELD122-217, pCMVTELD122-268, pCMV-TELD122-263, pCMVTELD268-303, and pCMVTELD303-333 plasmids were made by standard PCR techniques, and sequences to screen for further mutations. The rat stromelysin-1 reporter pGL2-754TR was described previously (Fenrick et al., 2000) . Plasmids encoding histone deacetylases and N-CoR have also been described (Grozinger et al., 1999; Kurokawa et al., 1995; Taunton et al., 1996) .
Cell culture, retroviral infection, transfection, and inhibitor assay
Production of retroviruses and infection of NIH3T3 to express Ras or Ras+TEL was previously described (Fenrick et al., 2000) . Trichostatin A was added to the culture medium to a ®nal concentration of 150 nM. Cell photographs were recorded using a Zeiss Axiophot microscope with a leaf Lumina digital camera (62.56magni®cation). Images were recorded as TIFF ®les in Adobe Photoshop.
Transient transcription assay
NIH3T3 cells were transfected with Qiagen superfect reagents with 1 mg pGL2-754TR reporter plasmid (Fenrick et al., 2000) . Cells and supernatants were harvested 48 h posttransfection. Cells were washed with PBS and lysed in 100 ± 200 ml of Reporter Lysis Buer (Promega). 10 ± 80 ml aliquots were assayed for luciferase activity using the Luciferase Reagent Assay (Promega) according to the manufacturer's instructions. pCMV ± SEAP (Secreted Alkaline Phosphatase) plasmids were included as internal controls for transfection eciency. SEAP activity was quantitated as described (Lutterbach et al., 1998) , except that the incubations were performed at room temperature. Luciferase activities were then normalized with respect to SEAP activity.
Chromatin immunoprecipitation (CHIP) assay
CHIP assay was performed according to the protocol from Upstate Biotechnology, Ras-expressing NIH3T3 cells were treated with 1% paraformaldehyde for 10 min at 378C with mild shaking. The cells were collected by centrifugation and resuspended in lysis buer (1% SDS, 10 mM EDTA, 50 mM Tris-HCl, pH 8.1). After a brief sonication, undissolved material was removed by centrifugation (13 000 r.p.m. in a microfuge). As a control, a portion of lysate was precipitated with ethanol and used directly for PCR. The remaining lysate was diluted 10-fold with dilution buer (0.01% SDS, 1% Triton, 1.2 mM EDTA, 16.7 mM Tris-HCl [pH 8.1], and 150 mM NaCl], and anti-acetylated histone H3 antibody was added and the mixture incubated at 48C overnight. Chromatin immunoprecipitates were collected using Protein A sepharose beads and washed with dilution buer. The chromosomal DNA was eluted with elution buer (1% SDS and 0.1 M NaHCO3). The protein : DNA crosslinking was reversed by the addition of 5 M NaCl. The eluted DNA was precipitated with ethanol and then treated with proteinase K. Finally, the DNA was recovered by phenol/chloroform extraction and precipitated with ethanol. Primers used for PCR were 5'-GCCAAGGCAGGAAGCATTTCCTGG-3'; 5'-CTAGGTCCACCTTCTTAAGCCCAAC-3' and PCR performed for 32 ± 35 cycles. In a given experiment 5 ± 7 additional cycles were required to see a product in the control samples. The size of the predicted PCR product was approximately 200 bp, which covers the region from TATA box to the classical ETS binding site of stromelysin-1 promoter (Fenrick et al., 2000) .
Immunoprecipitation assay
Cos-7 cells (3610 6 ) were transfected using Superfect (Qiagen) with 6 mg (total) of the indicated expression constructs. Cells were lysed in phosphate-buered saline supplemented with 1 mM EDTA, 16protease inhibitor cocktail (Roche), 0.5% Triton X-100, and 0.1% SDS. Before immunoprecipitation cell lysates were precleared with PANSORBIN (Calbiochem). Antibodies used for immunoblotting and immunoprecipitations were anti-mSin3A (K-20, Santa Cruz Biotechnology, Inc.), anti-FLAG (M2 antibody, Sigma), or anti-TEL (Fenrick et al., 2000) .
